Wagner Wealth Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Wagner Wealth Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	BUY	$548.35 - $738.84 $15,353 - $20,687	28 New	28 $17,000
Q1 2022 May 16, 2022	SELL	$595.12 - $698.43 $14,878 - $17,460	-25 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$574.03 - $680.96 $14,350 - $17,024	25 New	25 $16,000
Q2 2021 Aug 13, 2021	SELL	$472.8 - $558.54 $4,728 - $5,585	-10 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$446.73 - $548.2 $4,467 - $5,482	10 New	10 $5,000
Q2 2018 Aug 01, 2018	SELL	$284.6 - $344.99 $4,269 - $5,174	-15 Closed	0 $0
Q4 2017 Feb 22, 2018	BUY	$358.63 - $469.95 $5,379 - $7,049	15	15 $6,000

1,500

83M

1.22M

1.5M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $72.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Wagner Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Wagner Wealth Management, LLC with notifications on news.